VolumeRAD Digital Tomosynthesis

Today clinicians rely on standard radiography as the first diagnostic test for most chest, orthopedic and trauma cases. Advanced medical imaging is often ordered for complex cases that radiography cannot solve. These additional imaging modalities may result in higher radiation exposure, higher imaging costs, and a delay in diagnosis & treatment that could also mean more anxiety and discomfort for the patient.

VolumeRAD Digital Tomosynthesis brings 3-dimensional imaging into your radiography room, helping you resolve inconclusive x-rays "here and now" with minimal added radiation. Our cost-effective technology helps improve patient experience by providing additional information that could help make care decisions faster.

With VolumeRAD:

  • Obtain multiple cross-section images of the anatomy in a single sweep at a low dose, including chest, abdomen, extremities, spine, skull & sinuses
  • Resolve inconclusive x-rays in orthopedic & trauma cases efficiently
  • Achieve superior lung nodule detection sensitivity compared to conventional chest x-ray1
  • Improve patient experience with advanced imaging "here and now"

  • VolumeRAD Metal Artifact Reduction

    Metallic implants often cause difficulty in VolumeRAD imaging that result in undershoot (black lines appear in the x-ray), a “white ring” effect around hardware or multi-plane streaking throughout the image. VolumeRAD’s metal artifact reduction improves image quality by removing these effects and help:
    • Analyze implant placements
    • Increase clinical confidence
    • Improve visibility

How it works

Lung

VolumeRAD for lung nodule detection

Orthopedic

VolumeRAD for orthopedic practices

Gallery

  • VolumeRAD

  • VolumeRAD

Related Products

*7.5 times increase in lung nodule sensitivity for nodules between 4 mm and 6 mm diameter vs. standard X-Ray. No clinical evidence has been established supporting the following claims in patients with active lung or pleural disease that could obscure pulmonary nodules, including fibrosis, emphysema, compressed lung, scarring, severe lung disease, and in patients with objects in or around the lungs that could obscure pulmonary nodules. The effectiveness of the device may vary depending on nodule prevalence and type.

 

[1] No clinical evidence has been established supporting the following claims in patients with active lung or pleural disease that could obscure pulmonary nodules, including fibrosis, emphysema, compressed lung, scarring, severe lung disease, and in patients with objects in or around the lungs that could obscure pulmonary nodules. The effectiveness of the device may vary depending on nodule prevalence and type.

 

[2] Defined as a recommendations for further advanced imaging, based upon the Fleischner Society guidelines for pulmonary nodule management. MacMahon, Heber, et al. "Guidelines for Management of Small Pulmonary Nodules Detected on CT Scans: A Statement from the Fleischner Society." Radiology 237.2(2005):395-400.

JB01575IN

WIPRO GE HEALTHCARE PVT LTD
No. 4, Kadugodi Industrial Area,
Bangalore 560067,
Karnataka, India
CIN: U33111KA1990PTC01606
1800-102-2977 / +91 80 4180 1290
India.eCommerce@ge.com
Grievance Officer: Nestor J. Rivera
Chief Privacy Counsel/Officer, GE HealthCare